Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Esterling

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
JCO Precision Oncology|September 14, 2020
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year PeriodLisa Esterling, Ranjula Wijayatunge, Krystal Brown, et al.
JAMA|September 29, 2018
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic TestingJacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, et al.
Breast Cancer Research and Treatment|August 3, 2014
Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genesDmitry Pruss, Brian Morris, Elisha Hughes, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
JCO Precision Oncology|September 14, 2020
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year PeriodLisa Esterling, Ranjula Wijayatunge, Krystal Brown, et al.
JAMA|September 29, 2018
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic TestingJacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, et al.
Breast Cancer Research and Treatment|August 3, 2014
Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genesDmitry Pruss, Brian Morris, Elisha Hughes, et al.
Pageof 1